癌症和超生物体
Laurence Zitvogel1,2,3,4, Guido Kroemer1,5,6,7
1Gustave Roussy Cancer Campus, Villejuif, France.
Cancer discovery
|April 4, 2024
概括
肠道微生物群的转变与癌症的进展和免疫系统的变化有关. 未来的治疗将专注于诊断和纠正这些微生物失衡,以恢复健康.
科学领域:
- 微生物组研究的研究.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肠道微生物群失调与瘤进展有关.
- 微生物的变化可能会损害身体的免疫监测能力.
- 恢复肠道微生物平衡对于健康和疾病管理至关重要.
研究的目的:
- 要突出致病性肠道微生物群在癌症中的作用.
- 强调诊断和治疗纠正这些变化的必要性.
- 为了强调恢复元生物体恒温的重要性.
主要方法:
- 关于肠道微生物群和癌症的当前文献的综述.
- 在瘤进展过程中对肠道生态变化的分析.
- 讨论微生物群纠正的诊断和治疗策略.
主要成果:
- 致病性肠道微生物群的转变是瘤进展的组成部分.
- 这些变化会对免疫监测产生负面影响.
- 纠正微生物群失衡对于治疗策略至关重要.
结论:
- 对肠道微生物群变化的诊断和治疗纠正对于癌症管理至关重要.
- 准肠道微生物组为恢复健康提供了一个有希望的策略.
- 未来的医疗保健将整合基于微生物的方法来治疗疾病.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
What is Cancer?
10.7K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.7K
Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K


